Croydon Health Services NHS Trust adopts pioneering approach to research
A new way of setting up clinical trials means research projects at Croydon University Hospital will be quicker and easier to get started.
There are currently 41 research trials running at Croydon Health Services NHS Trust with £194,000 of funding from the Comprehensive Local Research Network (CLRN).
Patients across Croydon have now the opportunity to volunteer to be involved in ground breaking work and to receive potentially cutting-edge treatments.
The Trust is a founder member of the South West Research & Development Cluster which will take a new approach to clinical research, both within Croydon and across South London.
The cluster has been formed through a joint agreement between NHS Trusts and the NIHR London (South) CLRN, part of the National Institute for Health Research (NIHR).
There will now be a centralised function for researchers to gain the necessary permissions required to set-up and carry out NIHR clinical research in hospitals.
Research & Development Director at Croydon Health Services NHS Trust, Dr John Chang, said: "By becoming a founder member of the SW Cluster, we can help to speed up the processes needed to set up new medical studies."
Current research projects at Croydon Health Services NHS Trust include a study to investigate why some patients being treated for arthritis can become non-responsive or have adverse reactions to certain drugs used to treat the condition.
The study, which is in its second year, has 30 participants and looks at blood samples, diet and other life factors to see why this reaction occurs.
Steve Ebbs, Medical Director at Croydon Health Services NHS Trust added: "Medicine is changing all the time, as new procedures, methods and drugs become available and many conditions are now being treated more effectively as a result. Medical research is a key part of what the NHS does and I’m proud that we can play a part in delivering innovation and making medical discoveries"
Comments are closed on this article.